Kiyan Heybati
Overview
Explore the profile of Kiyan Heybati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie G, Estevez M, Heybati K, Vogt M, Smith M, Moshe C, et al.
Braz J Anesthesiol
. 2025 Mar;
75(2):844602.
PMID: 40023496
Background: Anesthesiologists are often tasked with overseeing sedation in non-surgical settings. We aim to determine whether adding adjuvant sedatives to propofol affects the recovery times and complication rates after endoscopy....
2.
Xie G, Estevez M, Heybati K, Vogt M, Smith M, Moshe C, et al.
Gastrointest Endosc
. 2025 Jan;
PMID: 39880215
Background And Aims: The use of anesthesia has become commonplace in many procedural settings. The goal of this study is to compare sedation modalities used by endoscopists and anesthesiologists in...
3.
Deng J, Heybati K, Yadav H
BMJ Open
. 2025 Jan;
15(1):e092594.
PMID: 39842934
Introduction: Propofol is a widely used sedative-hypnotic agent for critically ill patients requiring invasive mechanical ventilation (IMV). Despite its clinical benefits, propofol is associated with increased risks of hypertriglyceridemia. Early...
4.
Heirali A, Heybati K, Sereeyotin J, Khan F, Yarnell C, Krewulak K, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2454944.
PMID: 39821399
Importance: Eligibility criteria for randomized clinical trials (RCTs) are designed to select clinically relevant patient populations. However, not all eligibility criteria are strongly justified, potentially excluding marginalized groups, and limiting...
5.
Heybati K, Chang A, Mohamud H, Satkunasivam R, Coburn N, Salles A, et al.
BMC Health Serv Res
. 2025 Jan;
25(1):93.
PMID: 39819673
Background: Some prior studies have found that patients treated by female physicians may experience better outcomes, as well as lower healthcare costs than those treated by male physicians. Physician-patient sex...
6.
Heybati K, Deng J, Xie G, Poudel K, Zhou F, Rizwan Z, et al.
Ann Am Thorac Soc
. 2024 Oct;
22(2):235-246.
PMID: 39393346
Propofol is one of the first-line sedative-hypnotic agents for critically ill adults requiring mechanical ventilation. Although propofol can elevate triglyceride levels, and the latter is a risk factor for pancreatitis,...
7.
Deng J, Bedri N, Zuo Q, Azab M, Chang O, Virdi R, et al.
Pediatr Infect Dis J
. 2024 Sep;
44(1):74-82.
PMID: 39348497
Objective: To assess the efficacy and safety of corticosteroids for the management of pediatric sepsis and septic shock. Data Sources: Ovid MEDLINE, Ovid Embase, CENTRAL, Web of Science (Core Collection)...
8.
Heybati K, Satkunasivam R, Aminoltejari K, Thomas H, Salles A, Coburn N, et al.
Ann Surg Open
. 2024 Sep;
5(3):e477.
PMID: 39310349
Objective: The objective of this study was to measure potential associations between surgeon sex and number of days alive and at home (DAH). Background: Patients treated by female surgeons appear...
9.
Deng J, Heybati K, Yadav H
medRxiv
. 2024 Sep;
PMID: 39228709
Introduction: Propofol is a widely used sedative-hypnotic agent for critically-ill patients requiring invasive mechanical ventilation (IMV). Despite its clinical benefits, propofol is associated with increased risks of hypertriglyceridemia. Early identification...
10.
Deng J, Zuo Q, Venugopal K, Hung J, Zubair A, Blais S, et al.
Int Arch Allergy Immunol
. 2024 Jun;
185(10):997-1018.
PMID: 38870923
Introduction: This systematic review aimed to assess the efficacy and safety of hydrocortisone, ascorbic acid, and thiamine (HAT) combination therapy in patients with sepsis and septic shock. Methods: We conducted...